10 research outputs found
Comparison of 2018 AHA-ACC Multi-Society Cholesterol Guidelines with 2013 ACC-AHA Cholesterol Guidelines
No full textThe 2018 American Heart Association (AHA)–American College of Cardiology (ACC) Multi-Society Guideline on the Management of Blood Cholesterol provides an evidence-based update on the recommendations for lipid and lipoprotein management for the prevention of clinical atherosclerotic cardiovascular disease that were given in the 2013 ACC–AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. The 2018 Guideline also includes management recommendations for a variety of special populations, information on key laboratory issues impacting on lipid management, comments on the cost effectiveness of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, and identifies strategies that impact on adherence and implementation of guideline-directed medical therapy. This chapter compares the recommendations given in the two guideline documents and provides a foundation for the reader to incorporate the most current evidence-based recommendations for the management of lipid disorders into daily practice
New Recommendations and Revised Concepts in Recent Guidelines on the Management of Dyslipidemias to Prevent Cardiovascular Disease: the 2018 ACC/AHA and 2019 ESC/EAS Guidelines
No full textViscoelastic properties of clot formation and their clinical impact in East Asian versus Caucasian patients with stable coronary artery disease: a COMPARE-RACE analysis
No full textQuo vadis development: assessing the livelihood of indigenous people’s communities in Malaysia and the potential for community-based conservation effort
No full textAge, maturation and serum lipid parameters: findings from the German Health Survey for Children and Adolescents
No full text
